My Portfolio

Daiichi Sankyo Co Ltd 4568.T-JP:Tokyo Stock Exchange

*Data is delayed | Exchange | JPY

Last | 06/03/26 JST

2,517.00UNCH (UNCH)

52 week range

2,443.00 - 4,178.00

Open0.00
Day High0.00
Day Low0.00
Prev Close2,517.00
52 Week High4,178.00
52 Week High Date10/09/25
52 Week Low2,443.00
52 Week Low Date05/07/26

Latest On Daiichi Sankyo Co Ltd

Asia markets trade higher as hopes for a U.S.-Iran deal rise April 14, 2026CNBC.com
Banking on the long-term potential of oncology drugs: Daiichi Sankyo CFOFebruary 1, 2026CNBC.com
Importing a heavy truck carrying pharma drugs? Trump's new tariffs will hit hardSeptember 26, 2025CNBC.com
Asian pharma stocks extend declines after Trump slaps 100% levies on branded drugsSeptember 25, 2025CNBC.com
Australia stocks rise over 1%, crossing 9,000 threshold for the first timeAugust 20, 2025CNBC.com
Daiichi Sankyo has inventory buffer, will expand production capacity in Ohio to mitigate US tariffs - CFOJuly 31, 2025CNBC.com

Key Stats

Market Cap4.768T
Shares Out1.89B
10 Day Average Volume8.06M
Dividend100.00
Dividend Yield3.97%
Beta0.83

Latest On Daiichi Sankyo Co Ltd

Asia markets trade higher as hopes for a U.S.-Iran deal rise April 14, 2026CNBC.com
Banking on the long-term potential of oncology drugs: Daiichi Sankyo CFOFebruary 1, 2026CNBC.com
Importing a heavy truck carrying pharma drugs? Trump's new tariffs will hit hardSeptember 26, 2025CNBC.com
Asian pharma stocks extend declines after Trump slaps 100% levies on branded drugsSeptember 25, 2025CNBC.com
Australia stocks rise over 1%, crossing 9,000 threshold for the first timeAugust 20, 2025CNBC.com
Daiichi Sankyo has inventory buffer, will expand production capacity in Ohio to mitigate US tariffs - CFOJuly 31, 2025CNBC.com

KEY STATS

Open0.00
Day High0.00
Day Low0.00
Prev Close2,517.00
52 Week High4,178.00
52 Week High Date10/09/25
52 Week Low2,443.00
52 Week Low Date05/07/26
Market Cap4.768T
Shares Out1.89B
10 Day Average Volume8.06M
Dividend100.00
Dividend Yield3.97%
Beta0.83

RATIOS/PROFITABILITY

EPS (TTM)142.90
P/E (TTM)17.61
Fwd P/E (NTM)-
EBITDA (TTM)306.549B
ROE (TTM)15.81%
Revenue (TTM)2.123T
Gross Margin (TTM)68.49%
Net Margin (TTM)12.24%
Debt To Equity (MRQ)18.06%

EVENTS

Earnings Date-
Ex Div Date03/30/2026
Div Amount39.00
Split Date-
Split Factor-

Content From Our Affiliates

Bernstein Sticks to Its Buy Rating for Daiichi Sankyo Company (DSKYF)June 2, 2026TipRanks
SMBC Nikko Remains a Buy on Daiichi Sankyo Company (DSKYF)May 27, 2026TipRanks
Daiichi Sankyo Company (DSKYF) Receives a Buy from Mizuho SecuritiesMay 27, 2026TipRanks
Daiichi Sankyo Company (DSKYF) Receives a Buy from CitiMay 18, 2026TipRanks
Daiichi Sankyo Corrects FY2025 Presentation Materials Without Changing Financial ResultsMay 13, 2026TipRanks

Profile

Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the...

Sunao Manabe

Chairman of the Board, Representative Director

Takaaki Nishii

Chairman of the Board of Directors, Independent Director

Hiroyuki Okuzawa

President, Executive President, Chief Executive Officer, Representative Director

Koji Ogawa

Senior Managing Executive Officer, Chief Financial Officer, Head of Global Corporate Planning and Management

Address

Daiichi Sankyo Bldg. A/B Kan

3-5-1, Nihombashi Hon-cho

Chuo-ku, TKY

103-8426

Japan

https://www.daiichisankyo.co.jp/